GB9828068D0 - Controlled release vitamin B12 compositions and methods of using them - Google Patents
Controlled release vitamin B12 compositions and methods of using themInfo
- Publication number
- GB9828068D0 GB9828068D0 GBGB9828068.8A GB9828068A GB9828068D0 GB 9828068 D0 GB9828068 D0 GB 9828068D0 GB 9828068 A GB9828068 A GB 9828068A GB 9828068 D0 GB9828068 D0 GB 9828068D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- methods
- controlled release
- release vitamin
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ32944797 | 1997-12-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9828068D0 true GB9828068D0 (en) | 1999-02-17 |
GB2332374A GB2332374A (en) | 1999-06-23 |
GB2332374B GB2332374B (en) | 2002-11-06 |
Family
ID=19926561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9828068A Expired - Lifetime GB2332374B (en) | 1997-12-19 | 1998-12-18 | Controlled release vitamin B12 compositions and methods of using them |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU711760B2 (en) |
GB (1) | GB2332374B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ504631A (en) * | 2000-05-18 | 2002-02-01 | Agres Ltd | Gastro-intestinal sustained release bolus delivery system containing Duddingtonia flagrans |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5000886A (en) * | 1987-05-26 | 1991-03-19 | American Cyanamid Company | Silicone-hardened pharmaceutical microcapsules and process of making the same |
US5288496A (en) * | 1990-05-15 | 1994-02-22 | Stolle Research & Development Corporation | Growth promoters for animals |
EP0595030A3 (en) * | 1992-10-01 | 1995-06-07 | Tanabe Seiyaku Co | Sustained release multi-core microsphere preparation and method for producing the same. |
-
1998
- 1998-12-18 GB GB9828068A patent/GB2332374B/en not_active Expired - Lifetime
- 1998-12-18 AU AU98229/98A patent/AU711760B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU9822998A (en) | 1999-07-08 |
AU711760B2 (en) | 1999-10-21 |
GB2332374B (en) | 2002-11-06 |
GB2332374A (en) | 1999-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1019100A4 (en) | Controlled release of substances | |
HUP0003526A2 (en) | The use of delayed and/or sustained release vitamin d formulations and pharmaceutical compositions containing d-vitamins | |
SG71879A1 (en) | Controlled release compositions | |
IL223035A0 (en) | Extended release formulations of clarithromycin | |
EG23934A (en) | Poroxetine controlled release compositions | |
CY2284B1 (en) | Tablet with controlled release of alfuzosine chlorydrate | |
GB9826662D0 (en) | Controlled release formulation | |
IL116066A0 (en) | Controlled release caffeine composition and its preparation | |
PL325691A1 (en) | Derivatives of dithiolane, method of obtaining them and their therapeutic effects | |
ZA982188B (en) | Compositions and methods for reducing ocular hyper-tension | |
HUP0003745A3 (en) | Methods and compositions for inducing tumor-specific cytotoxicity | |
ZA968322B (en) | Solid sillicone compositions and methods for their preparation and use | |
IL120843A0 (en) | Vitamin D3 analogs and their uses | |
IL139848A0 (en) | Vitamin b12 derivatives and methods for their preparation | |
SG71789A1 (en) | Controlled release compositions | |
IL122642A0 (en) | Substituted purine derivatives processes for their preparation their use and compositions comprising them | |
PL338614A1 (en) | O-substituted derivatives of hydroxyenmarone as anticarcinogenic and antinetastic agents | |
PL331344A1 (en) | Acryloyl-substituted derivatives of distamycin, method of obtaining them and their application as anticarcinogenic and antiviral agents | |
PL329878A1 (en) | Derivatives of distamycin, method of obtaining them and their application as anticarcinogenic and antiviral agents | |
AU1502799A (en) | Pharmaceutical composition comprising clioquinol and vitamin B12 | |
GB9621570D0 (en) | Formulations and methods for inhibiting bone loss | |
EP1127860A4 (en) | Pyrotechnic composition and method for preparation thereof | |
IL119142A0 (en) | Slow release formulations of pesticides | |
HUP0002928A3 (en) | Stable solid preparation containing vitamin d3 and tricalcium phosphate and process for its preparation | |
GB2332374B (en) | Controlled release vitamin B12 compositions and methods of using them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Expiry date: 20181217 |